Suzetrigine in Total Hip Arthroplasty
Recruiting
Phase 3
Interventional Study
Total Hip Arthroplasty (THA)
Total Hip Arthroplasty \(THA\)
Total Hip Replacement
Total Hip Replacement Surgery
Total Hip Replacements
Total Hip Replacement Arthroplasty
Suzetrigine
Pain Management
Pain
Nav 1.8
JOURNAVX
Opioid Cessation
Opioid Consumption, Postoperative
Multimodal Analgesia
Randomized Controlled Trial
Randomized Controlled Study
Randomized Controlled Trials
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 210 (estimated)
- Sponsor
- Hospital for Special Surgery, New York · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Total hip and knee joint replacements are among the most common and painful orthopedic procedures performed worldwide, often requiring intensive analgesia to support early ambulation and recovery. Despite widespread use of multimodal regimens, many patients still rely on opioids, which can cause sedation, nausea, constipation, and long-term dependency. Evaluating Suzetrigine in this high-need popu…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients undergoing primary THA (posterior approach) with participating surgeons
* Age 18 to 80 years old
* Planned discharge to home
* Planned use of neuraxial anesthesia
* American Society of Anesthesiologists (ASA) Physical Status 1 - 3
Exclusion Criteria:
* ASA greater t…
Contacts